Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.28B |
| 2 |
Amgen
AMGN
|
+$1.18B |
| 3 |
Gilead Sciences
GILD
|
+$1.16B |
| 4 |
CTRA
Coterra Energy
CTRA
|
+$868M |
| 5 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$570M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$3.97B |
| 2 |
AGN
Allergan Inc
AGN
|
+$2.33B |
| 3 |
United Parcel Service
UPS
|
+$1.25B |
| 4 |
CVS Health
CVS
|
+$1.01B |
| 5 |
Capital One
COF
|
+$963M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.19% |
| 2 | Technology | 12.85% |
| 3 | Industrials | 11.43% |
| 4 | Communication Services | 10.57% |
| 5 | Energy | 8.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
lululemon athletica
LULU
$13.7B
| $573M | 0.2% |
14,151,637
+382,440
| +3% | +$17.4M |
|
127
Palo Alto Networks
PANW
$315B
| $571M | 0.2% |
40,841,874
| – | – |
|
128
Salesforce
CRM
$158B
| $555M | 0.19% |
+9,554,802
| New | +$516M |
|
129
Southern Company
SO
$106B
| $545M | 0.19% |
12,000,000
+750,000
| +7% | +$33.2M |
|
130
Williams-Sonoma
WSM
$28.9B
| $519M | 0.18% |
14,452,000
| – | – |
|
|
ONIT
131
Onity Group
ONIT
$321M
| $501M | 0.18% |
900,171
-103,488
| -10% | -$56.3M |
|
|
CIT
132
DELISTED
CIT Group Inc.
CIT
| $495M | 0.17% |
10,821,500
+450,000
| +4% | +$20.3M |
|
133
DTE Energy
DTE
$28.9B
| $483M | 0.17% |
7,286,763
| – | – |
|
134
Cisco
CSCO
$488B
| $481M | 0.17% |
19,336,350
+13,336,350
| +222% | +$318M |
|
135
NextEra Energy
NEE
$179B
| $464M | 0.16% |
18,127,808
| – | – |
|
136
BorgWarner
BWA
$14B
| $453M | 0.16% |
7,902,243
+1,296,176
| +20% | +$71.4M |
|
|
RAI
137
DELISTED
Reynolds American Inc
RAI
| $439M | 0.15% |
14,542,664
| – | – |
|
138
Merck
MRK
$328B
| $437M | 0.15% |
7,915,738
| – | – |
|
139
Citigroup
C
$231B
| $426M | 0.15% |
9,039,000
+850,000
| +10% | +$40.4M |
|
|
GEVA
140
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
| $424M | 0.15% |
4,044,761
+10,124
| +0.3% | +$861K |
|
141
Berkshire Hathaway Class B
BRK.B
$1.09T
| $423M | 0.15% |
3,341,280
+470,000
| +16% | +$59.5M |
|
142
Starwood Property Trust
STWD
$6.09B
| $416M | 0.15% |
17,509,000
-63,000
| -0.4% | -$1.5M |
|
143
Verisk Analytics
VRSK
$23.5B
| $414M | 0.14% |
6,903,300
+263,000
| +4% | +$15.7M |
|
|
ATHN
144
DELISTED
Athenahealth, Inc.
ATHN
| $410M | 0.14% |
3,273,403
+909,900
| +38% | +$118M |
|
145
PACCAR
PCAR
$69B
| $401M | 0.14% |
9,563,700
-3,148,650
| -25% | -$134M |
|
146
Conagra Brands
CAG
$7.16B
| $397M | 0.14% |
17,181,864
| – | – |
|
|
GRMN
147
Garmin
GRMN
$59.8B
| $396M | 0.14% |
6,500,000
-986,832
| -13% | -$56.7M |
|
|
MON
148
DELISTED
Monsanto Co
MON
| $395M | 0.14% |
+3,168,243
| New | +$371M |
|
149
Duke Energy
DUK
$96.3B
| $395M | 0.14% |
5,319,334
| – | – |
|
150
Dover
DOV
$28B
| $393M | 0.14% |
5,344,668
+619,000
| +13% | +$43.3M |
|
Similar funds
Capital Research Global Investors's Q2 2014 Portfolio in Review
As of Q2 2014, Capital Research Global Investors held 459 positions worth $286B, up 3.3% from $277B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Capital Research Global Investors's Q2 2014 filing shows 42 new, 135 increased, 98 reduced and 24 closed positions. Its largest new stake was CONCHO RESOURCES INC.: 4,296,000 shares worth $621M. The largest sale was Alphabet (Google) Class C, an estimated $3.97B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Technology and Industrials.
- Capital Research Global Investors's largest Q2 2014 buy was CONCHO RESOURCES INC.: 4,296,000 shares worth $621M.
- Capital Research Global Investors added most to Amazon in Q2 2014, an estimated $1.28B increase.
- Capital Research Global Investors's biggest Q2 2014 reduction was Alphabet (Google) Class C, cutting an estimated $3.97B.
- Capital Research Global Investors fully exited Allergan Inc in Q2 2014, selling an estimated $2.33B.
- Capital Research Global Investors's ten largest holdings make up 25% of its $286B portfolio in Q2 2014.
- Capital Research Global Investors opened 42 new positions and closed 24 in Q2 2014.
- Capital Research Global Investors's portfolio value rose 3.3% quarter-over-quarter to $286B.
Based on Capital Research Global Investors's 13F filing for Q2 2014, filed 14 Aug 2014.